Compare · CCEL vs SHC
CCEL vs SHC
Side-by-side comparison of Cryo-Cell International Inc. (CCEL) and Sotera Health Company (SHC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CCEL and SHC operate in Misc Health and Biotechnology Services (Health Care), so they compete in similar markets.
- SHC is the larger of the two at $5.88B, about 70.6x CCEL ($83.3M).
- SHC has been more active in the news (4 items in the past 4 weeks vs 2 for CCEL).
- SHC has more recent analyst coverage (25 ratings vs 0 for CCEL).
- Company
- Cryo-Cell International Inc.
- Sotera Health Company
- Price
- $3.59-2.18%
- $15.59+1.63%
- Market cap
- $83.3M
- $5.88B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Misc Health and Biotechnology Services
- Misc Health and Biotechnology Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2022
- 2020
- News (4w)
- 2
- 4
- Recent ratings
- 0
- 25
Cryo-Cell International Inc.
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, kidney, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
Sotera Health Company
Sotera Health Company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the Americas, Europe and Asia. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
Latest CCEL
- SEC Form 10-Q filed by Cryo-Cell International Inc.
- Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2026 Financial Results
- Cryo-Cell International Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits
- Cryo-Cell Receives NYSE American Continued Listing Notice
- SEC Form 10-K filed by Cryo-Cell International Inc.
- Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2025
- SEC Form 4 filed by Chairman, Co-CEO Portnoy David
- SEC Form 4 filed by Co-CEO Portnoy Mark L.
- SEC Form 4 filed by Chief Information Officer Mikulinsky Oleg
- SEC Form 4 filed by VP Finance, CFO Taymans Jill M
Latest SHC
- Sotera Health Announces First-Quarter 2026 Earnings Release Date
- SEC Form DEFA14A filed by Sotera Health Company
- SEC Form DEF 14A filed by Sotera Health Company
- SEC Form 3 filed by new insider Ostrowski Erika
- SEC Form 4 filed by Dimitrief Alexander
- Amendment: SEC Form SCHEDULE 13G/A filed by Sotera Health Company
- SEC Form 3 filed by new insider Krause Kenneth D.
- Sotera Health Company filed SEC Form 8-K: Leadership Update
- Sotera Health Appoints Kenneth D. Krause to the Board of Directors
- Director Warburg Pincus & Co. sold $229,050,000 worth of shares (15,000,000 units at $15.27) (SEC Form 4)